In an intention-to-treat analysis, mean weight loss was significantly greater in the high- and low-dose bupropion/naltrexone groups than in the placebo group (–6.1%, –5.0%, and –1.3% ...

Contrave (naltrexone/bupropion ... It’s also higher at the start of treatment and after a dose change. In studies of Contrave for weight loss, the medication did not increase the risk of ...

Data on the use and dosage of GLP-1 analogs, bupropion, and naltrexone were collected. Further, data on other weight loss-related medications, such as sodium-glucose cotransporter-2 inhibitors ...